The effects of a muscle resistance program on the functional capacity, knee extensor muscle strength and plasma levels of IL-6 and TNF-alpha in pre-frail elderly women: a randomized crossover clinical trial--a study protocol

Lygia P Lustosa, Fernanda M Coelho, Juscelio P Silva, Daniele S Pereira, Adriana N Parentoni, João M D Dias, Rosangela C Dias, Leani S M Pereira, Lygia P Lustosa, Fernanda M Coelho, Juscelio P Silva, Daniele S Pereira, Adriana N Parentoni, João M D Dias, Rosangela C Dias, Leani S M Pereira

Abstract

Background: With the increase in the elderly population, a growing number of chronic degenerative diseases and a greater dependency on caregivers have been observed. Elderly persons in states of frailty remain more susceptible to significant health complications. There is evidence of an inverse relationship between plasma levels of inflammatory mediators and levels of functionality and muscle strength, suggesting that muscle-strengthening measures can aid in inflammatory conditions. The purpose of this study will be verified the effect of a muscle-strengthening program with load during a ten-week period in pre-frail elderly women with attention to the following outcomes: (1) plasma levels of interleukin-6 (IL-6) and tumor necrosis factor alpha (TNF-alpha), (2) functional capacity and (3) knee extensor muscle strength.

Methods/design: The study design is a randomized crossover clinical trial evaluating 26 elderly women (regardless of their race and/or social condition) who are community residents, older than 65, and classified as pre-frail according to the criteria previously described by Fried et al. (2004). All subjects will be assessed using the Timed up and go and 10-Meter Walk Test functional tests. The plasma levels of IL-6 and TNF-alpha will be assessed by ELISA (enzyme-linked immunosorbent assay) with high sensitivity kits (QuantikineHS, R&D Systems Minneapolis, MN, U.S.). Knee extensor muscle strength will be assessed using the Byodex System 3 Pro(R) isokinetic dynamometer at angular speeds of 60 and 180 degrees/s. The intervention will consist of strengthening exercises of the lower extremities at 50 to 70% of 1RM (maximal resistance) three times per week for ten weeks. The volunteers will be randomized into two groups: group E, the intervention group, and group C, the control group that did not initiate any new activities during the initial study period (ten weeks). After the initial period, group C will begin the intervention and group E will maintain everyday activities without exercising. At the end of the total study period, all volunteers will be reassessed.

Discussion: To demonstrate and discuss possible influences of load-bearing exercises on the modification of plasma levels of IL-6 and TNF-alpha and in the functional performance of pre-frail elderly women.

Trial registration: ISRCTN62824599.

Figures

Figure 1
Figure 1

References

    1. Carvalho JAM, Rodriíguez-Wong LL. A transição da estrutura etária da população brasileira na primeira metade do século XXI. Cad Saúde Pública. 2008;24(3):597–605.
    1. Veras R. Envelhecimento populacional contemporâneo: demandas, desafios e inovações. Rev Saúde Pública. 2009;43(3):548–54.
    1. Walston J, Hadley E, Ferrucci L, Guralnik J, Newman A, Studensk A, William B, Ershler M, Harris T, Fried LP. Research Agenda for Frailty in Older Adults: Toward a Better Understanding of Physiology and Etiology: Summary from the American Geriatrics Society/National Institute on Aging Research Conference on Frailty in Older Adults. J Am Geriatr Soc. 2006;54:991–1001. doi: 10.1111/j.1532-5415.2006.00745.x.
    1. Fried LP, Ferrucci L, Darer J, Williamson JD, Anderson G. Untangling the concepts of disability, frailty, and comorbidity: implications for improved targeting and care. Journal of Gerontology: Med Sci. 2004;59(3):255–63.
    1. Fried LP, Tangen CM, Walston J, Newman AB, Hirsch C, Gottdiener J, Seeman T, Tracy R, Kop WJ, Burke G, McBurnie MA;. Cardiovascular Health Study Collaborative Research Group. Frailty in older adults: Evidence for a phenotype. J Gerontol A Biol Sci Med Sci. 2001;56:146–56.
    1. Ershler WB, Keller ET. Aged-associated increased interleukin-6 gene expression, late-life diseases, and frailty. Annu Rev Med. 2000;51:245–70. doi: 10.1146/annurev.med.51.1.245.
    1. Cohen HJ, Harris T, Pieper CF. Coagulation and activation of inflammatory pathways in the development of functional decline and mortality in the elderly. Am J Med. 2003;114:180–7. doi: 10.1016/S0002-9343(02)01484-5.
    1. Ferrucci L, Penninx BW, Volpato S, Harris TB, Bandeen-Roche K, Balfour J, Leveille SG, Fried LP, Md JM. Change in muscle strength explains accelerated decline of physical function in older women with high interleukin-6 serum levels. J Am Geritr Soc. 2002;50:1947–54. doi: 10.1046/j.1532-5415.2002.50605.x.
    1. Doherty TJ. Physiology of aging. Invited review: aging and sarcopenia. J Appl Physiol. 2003;95:1717–27.
    1. Roubenoff R. Catabolism of aging: is it an inflammatory process? Curr Opin Nutr Metab Care. 2003;6:295–9. doi: 10.1097/00075197-200305000-00005.
    1. Schaap L, Pluijm MFS, Deeg DJH, Visser M. Inflammatory markers and loss muscle mass (Sarcopenia) and strength. Am J of Med. 2006;119:526–7. doi: 10.1016/j.amjmed.2005.10.049.
    1. Pedersen BK. IL-6 signalling in exercise and desease. Biochemical Society Transactions. 2007. pp. 1295–7.
    1. Krabbe KS, Pedersen MP, Bruunsgaard H. Inflammatory mediators in the elderly. Experimental Gerontol. 2004;39:687–99. doi: 10.1016/j.exger.2004.01.009.
    1. Bruunsgaard H. Physical activity and modulation of systemic low-level inflammation. L Leukoc Biol. 2005;78:819–35. doi: 10.1189/jlb.0505247.
    1. Abbas AK, Lichtman AH, Pillai S. Imunologia Celular e Molecular. Rio de Janeiro: Elsevier; 2008. 6a.
    1. Greiwe JS, Cheng B, Rubin DC, Yarasheski KE, Semenkovich CF. Resistance exercise decreases skeletal muscle tumor necrosis factor a in frail elderly humans. Faseb J. 2001;15:475–82. doi: 10.1096/fj.00-0274com.
    1. Ferrucci L, Guralnik JM, Studensk S, Fried LP, Cutler GB, Walston JD. Designing randomized, controlled trials aimed at preventing or delaying functional decline and disability in frail, older persons: a consensus report. J Am Geriatr Soc. 2004;52:625–34. doi: 10.1111/j.1532-5415.2004.52174.x.
    1. Matiello-Sverzut AC. Histopatologia do músculo esquelético no processo de envelhecimento e fundamentação para a prática terapêutica de exercícios físicos e prevenção da sarcopenia. Rev Fisioter Univ SP. 2003;10:24–33.
    1. Petersen AMW, Pedersen BK. The anti-inflammatory effect of exercise. J Appl Physiol. 2005;98:1154–62. doi: 10.1152/japplphysiol.00164.2004.
    1. Reuben DB, Judd-Hamilton L, Harris TB, Seeman TE. The associations between physical activity and inflammatory markers in high-functioning older persons: MacArthur studies of successful aging. J Am Geriatr Soc. 2003;51:1125–30. doi: 10.1046/j.1532-5415.2003.51380.x.
    1. Maciel ACC, Guerra RO. Prevalência e fatores associados ao déficit de equilíbrio em idosos. Rev Bras Ciências e Mov. 2005;13(1):37–44.
    1. Drukker M, DeBie RA, VanRossum E. The effects of exercise training in institutionalized elderly people: a systematic review. Phys Ther Reviews. 2001;6(4):273–85.
    1. Febbraio MA, Pedersen BK. Muscle-derived interleukin-6: mechanisms for activation and possible biological roles. Faseb J. 2002;16:1335–47. doi: 10.1096/fj.01-0876rev.
    1. Drela N, Kozdron E, Szczypiorski P. Moderate exercise may attenuate some aspects of immunosenescence. BMC Geriatrics. 2004;4:8–10. doi: 10.1186/1471-2318-4-8.
    1. Eyigor S, Karapolat H, Durmaz B. Effects of a group-based exercise programo n the physical performance, muscle strength and quality of life in older women. Arch Gerontol Geriat. 2007;45(3):259–71. doi: 10.1016/j.archger.2006.12.001.
    1. Tracy BL, Ivey FM, Hurbut D, Martel GF, Lemmer JT, Siegel EL, Metter EJ, Fozard JL, Fleg JL, Hurley BF. Muscle quality II. Effects of strength training in 65 to 75 yr-old men and women. J Appl Physiol. 1999;86(1):195–201.
    1. Kryger AI, Andersen JL. Resistence training in the oldest old: consequences for muscle strength, fiber types, fiber size and MHC isoforms. Scand J Med Sci Sports. 2007;17:422–30. doi: 10.1111/j.1600-0838.2006.00575.x.
    1. Plomgaard P, Keller P, Keller C, Pedersen BK. TNF-α, but not IL-6, stimulates plasminogen activator inhibitor-1 expression in human subcutaneous adipose tissue. J Appl Physiol. 2005;95:2019–23. doi: 10.1152/japplphysiol.01220.2004.
    1. Paixão CM Jr, Reichenheim ME. Uma revisão sobre instrumentos de avaliação do estado funcional do idoso. Cad Saúde Pub. 2005;21(1):7–19.
    1. Huang MH, Lin YS, Yang RC, Lee CL. A comparison of various therapeutic exercises on the functional status of patients with knee osteoarthritis. Semin Arthritis Rheum. 2003;32(6):398–406. doi: 10.1053/sarh.2003.50021.
    1. Bertolucci P, Brucki S, Campacci S. O mini-exame do estado mental em uma população geral. Arq Neuropsiquiatr. 1994;52(1):1–7.
    1. Alaaeddine N, DiBattista JA, Pelletier JP, Cloutier JM, Kiansa K, Dupuis M, Martel-Pelletier. Osteoarthritic synovial fibroblasts possess an increased level of tumor necrosis factor-receptor 55 (TNF-R55) that mediates biological activation by TNF-alpha. J Rheumatol. 1997;24(10):1985–94.
    1. Podsiadlo D, Richardson S. The Timed Up & Go: a test of basic functional mobility for frail elderly persons. Jags. 1991;39:142–8.
    1. Shinkai S, Watanabe S, Kumagai S, Fujiwara Y, Amano H, Yoshida H, Ishizaki T, Yakawa H, Suzuki T, Shibata H. Walking speed as a good predictor for the onset of functional dependence in a Japanese rural community population. Age and Ageing. 2000. pp. 441–6.
    1. Baltzopoulos V, Brodie DA. Isokinetic dynamometry, applications and limitations. Sports Med. 1989;8(2):101–16. doi: 10.2165/00007256-198908020-00003.
    1. Oliveira DMG, Narciso FMS, Santos MLA, Pereira DS, Coelho FM, Dias JMD, Pereira LSM. Muscle strength but not functional capacity is associated with plasma interleukin-6 levels of community-dwelling elderly women. Brazil J Med and Biol Res. 2008;41:1148–53.
    1. Haack M, Pollmacher T, Mullington JM. Diurnal and sleep-wake dependent variations of soluble TNF- and IL-2 receptors in health volunteers. Brain, Behavior, and Immunity. 2004;18:361–67. doi: 10.1016/j.bbi.2003.12.009.
    1. Liebmann PM, Reibnegger G, Lehofer M, Moser M, Purstner P, Mangge H, Schauenstein K. Circadian rhythm of the soluble p75 tumor necrosis factor (sTNF-r75) receptor in humans - a possible explanation for the circadian kinetics of TNR-a effects. Inter Immunol. 1998;10(9):1393–6. doi: 10.1093/intimm/10.9.1393.
    1. Portney LG, Watkins MP. Foundations of clinical research: applications to practice. 2. New Jersey: Prentice Hall, Inc; 2000.
    1. Pereira LSM, Silva FMP, Oliveira DGM, Coelho FM, Souza DG, Dias RC. Correlation between manual muscle strength and interleukin-6 (IL-6) plasma levels in elderly community-dwelling women. Archiv Gerontol and Ger. 2009;48:313–16. doi: 10.1016/j.archger.2008.02.012.

Source: PubMed

Sponsors and Collaborators

Medical Conditions

Drug Interventions

3
Subscribe